“As the country prepares to celebrate National Cancer Survivors Dayâ, our primary motivation is to raise awareness of radiation cystitis and hemorrhagic cystitis, serious survivor issues that d ...

Up to 40 percent of treated patients, however, go on to develop some degree of hemorrhagic cystitis, a debilitating condition characterized by severe inflammation in the bladder that can lead to ...

Please provide your email address to receive an email when new articles are posted on . BK virus-specific cytotoxic T lymphocytes from healthy donors appeared safe and effective for patients with ...

Back to Healio The FDA granted orphan drug designation to posoleucel for the treatment of virus-associated hemorrhagic cystitis, according to the agent’s manufacturer. Virus-associated ...

About Hemorrhagic Cystitis Radiation used to treat prostate, colon, uterine, cervical and other pelvic cancers can cause chronic, painful urinary inflammation and blood loss called hemorrhagic ...

April 28, 2005 — Hyperbaric oxygen (HBO 2) therapy given within six months of hematuria onset is effective for radiation-induced hemorrhagic cystitis, according to the results of a retrospective ...

The Food and Drug Administration (FDA) has granted Orphan Drug designation to posoleucel (Viralym-M, ALVR105) for the treatment of virus-associated hemorrhagic cystitis.

The LP-10 Phase 2a clinical trial was a multi-center, dose-escalation study, which recruited 13 subjects with moderate to severe refractory hemorrhagic cystitis. These subjects were treated with ...

NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView presents an exclusive Q&A with Dr. Michael Chancellor, Co-founder and Chief Medical Officer of Lipella Pharmaceuticals, Inc. (Nasdaq ...

We report a case of severe hemorrhagic cystitis complicating high-dose cyclophosphamide (CY), total body irradiation and allogeneic hematopoietic stem cell transplantation (HSCT). Supportive care ...

The LP-10 Phase 2a clinical trial was a multi-center, dose-escalation study, which recruited 13 subjects with moderate to severe refractory hemorrhagic cystitis.